COVID-19 and Severely Impaired B-cell Function research hub

Randomized Open Label Trial Evaluating Efficacy and Safety of Intravenous Immunoglobulin (IVIg, Privigen) as Add-on to SoC Versus SoC Alone for Coronavirus Disease 2019 (COVID-19) in Patients with Severely Impaired B-cell Function

This study is testing a medicine called Privigen for people with COVID-19 who have a weakened immune system. It aims to see if adding Privigen to standard care helps them recover better than standard care alone.